BioRestorative Therapies, Inc. (BRTX)
NASDAQ: BRTX · IEX Real-Time Price · USD
1.650
-0.020 (-1.20%)
At close: Jul 19, 2024, 4:00 PM
1.640
-0.010 (-0.61%)
Pre-market: Jul 22, 2024, 7:44 AM EDT

BioRestorative Therapies Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019 2018 - 2009
Revenue
0.150.150.120.050.080.13
Upgrade
Revenue Growth (YoY)
10.66%21.70%160.43%-40.26%-40.77%17.12%
Upgrade
Gross Profit
0.150.150.120.050.080.13
Upgrade
Selling, General & Admin
10.1211.3315.5825.621.956.84
Upgrade
Research & Development
3.584.033.510.730.881.72
Upgrade
Operating Expenses
13.715.3719.0926.352.838.56
Upgrade
Operating Income
-13.55-15.22-18.97-26.31-2.75-8.43
Upgrade
Interest Expense / Income
0.02001.821.641.47
Upgrade
Other Expense / Income
-6.61-4.8-5.7516.186.884.75
Upgrade
Pretax Income
-6.96-10.42-13.22-44.3-11.27-14.65
Upgrade
Net Income
-6.96-10.42-13.22-44.3-11.27-14.65
Upgrade
Shares Outstanding (Basic)
744100
Upgrade
Shares Outstanding (Diluted)
744100
Upgrade
Shares Change
79.46%16.60%204.60%200.92%6987.54%-99.71%
Upgrade
EPS (Basic)
-1.36-2.47-3.65-37.30-28.56-2640.00
Upgrade
EPS (Diluted)
-1.36-2.47-3.65-37.30-28.56-2640.00
Upgrade
Free Cash Flow
-6.51-6.6-6.18-3.36-1.96-6.95
Upgrade
Free Cash Flow Per Share
-0.98-1.56-1.71-2.83-4.98-1248.69
Upgrade
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Upgrade
Operating Margin
-9064.17%-10439.49%-15838.08%-57191.03%-3574.12%-6486.16%
Upgrade
Profit Margin
-4653.34%-7145.20%-11036.97%-96311.51%-14639.85%-11267.61%
Upgrade
Free Cash Flow Margin
-4354.70%-4527.61%-5157.20%-7305.58%-2550.99%-5349.51%
Upgrade
EBITDA
-6.67-10.16-12.94-42.28-9.48-12.95
Upgrade
EBITDA Margin
-4462.92%-6969.59%-10802.70%-91919.08%-12312.44%-9957.78%
Upgrade
Depreciation & Amortization
0.270.260.280.210.150.23
Upgrade
EBIT
-6.94-10.42-13.22-42.49-9.63-13.18
Upgrade
EBIT Margin
-4641.15%-7145.20%-11036.97%-92365.06%-12509.79%-10138.41%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).